| |  Online-Ressource |
|---|
| Verfasst von: | Kremer, Jamila [VerfasserIn]  |
|---|
| | El-Dor, Abbas [VerfasserIn] |
|---|
| | Rivinius, Rasmus [VerfasserIn] |
|---|
| | Schlegel, Philipp [VerfasserIn] |
|---|
| | Sommer, Wiebke [VerfasserIn] |
|---|
| | Warnecke, Gregor [VerfasserIn] |
|---|
| | Karck, Matthias [VerfasserIn] |
|---|
| | Ruhparwar, Arjang [VerfasserIn] |
|---|
| | Meyer, Anna L. [VerfasserIn] |
|---|
| Titel: | Wound infections in adult patients after Berlin Heart EXCOR biventricular assist device implantation |
|---|
| Verf.angabe: | Jamila Kremer, Abbas El-Dor, Rasmus Rivinius, Philipp Schlegel, Wiebke Sommer, Gregor Warnecke, Matthias Karck, Arjang Ruhparwar and Anna L. Meyer |
|---|
| E-Jahr: | 2022 |
|---|
| Jahr: | 6 October 2022 |
|---|
| Umfang: | 11 S. |
|---|
| Fussnoten: | Gesehen am 15.02.2023 |
|---|
| Titel Quelle: | Enthalten in: Life |
|---|
| Ort Quelle: | Basel : MDPI, 2011 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 12(2022), 10, Artikel-ID 1550, Seite 1-11 |
|---|
| ISSN Quelle: | 2075-1729 |
|---|
| Abstract: | The Berlin Heart® EXCOR is a paracorporeal, pulsatile ventricular assist device used in patients of all age groups. However, adolescent and adult patients on EXCOR support are scarcely explored. Herein, we present a detailed description of infectious complications in this patient cohort. From 2006 to 2020, 58 patients received a biventricular assist device (BiVAD) at our institution and were included in this study. Postoperative infections were assessed after BiVAD implantation and subsequent heart transplantation (HTx). A Berlin Heart® EXCOR BiVAD was implanted as a bridge to transplantation in 58 patients (12-64 years). Most patients were INTERMACS I, and their median age was 49 years. Wound infections (WI) specific to the ventricular assist device (VAD) occurred in 31 (53.4%) patients with a mean time of 113 ± 155 days after BiVAD implantation. HTx was performed in 30 (51.7%) patients and thereof 10 (33.3%) patients developed at least one WI post-HTx. The mean time of WI after HTx was 17 ± 14 days. In four cases, WIs were caused by the same pathogen as before HTx. According to our institutional BiVAD wound classification, the mean wound score was 3. The VAD-specific wound infections were manageable and did not increase mortality nor precluded HTx in Berlin Heart® EXCOR patients. No specific risk factors for VAD-specific wound infections could be identified. |
|---|
| DOI: | doi:10.3390/life12101550 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.3390/life12101550 |
|---|
| | Volltext: https://www.mdpi.com/2075-1729/12/10/1550 |
|---|
| | DOI: https://doi.org/10.3390/life12101550 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Berlin Heart<sup>®</sup> EXCOR system |
|---|
| | biventricular assist device (BiVAD) |
|---|
| | heart transplantation |
|---|
| | infections |
|---|
| | mechanical circulatory support |
|---|
| K10plus-PPN: | 1835731961 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Wound infections in adult patients after Berlin Heart EXCOR biventricular assist device implantation / Kremer, Jamila [VerfasserIn]; 6 October 2022 (Online-Ressource)
